Scientists at Johnson & Johnson (JNJ.N) on Friday refuted an assertion in a major medical journal that the design of their COVID-19 vaccine, which is similar AstraZeneca’s (AZN.L), may explain why both have been linked to very rare brain blood clots in some vaccine recipients.
Swiss chemicals maker Sika AG on Tuesday reported a 13.8% increase in its first-quarter sales and confirmed its outlook for 2024.
Drug regulators in Tanzania, Rwanda and Zimbabwe have recalled a batch of Johnson & Johnson children’s cough syrup as a precautionary measure after their Nigerian…
Neumora Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on early-stage study of its experimental schizophrenia drug,…
A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been badly mismanaged and nominated two candidates to serve on Novavax’s…
The cybersecurity firm BrandShield has taken down more than 250 websites selling fake versions of popular weight-loss and diabetes drugs in the GLP-1 class, the…
UnitedHealth is expected to record higher medical costs in its first earnings report since a cyberattack disrupted its technology systems including those that manage prescription…
Drug regulators in Tanzania and Rwanda have recalled a batch of Johnson & Johnson children’s cough syrup as a precautionary measure after their Nigerian counterpart…
The European Union is set to launch an investigation into China’s procurement of medical devices to address concerns that Beijing’s policies are unfairly favouring domestic…
Neumora Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical hold on early-stage study of its experimental schizophrenia drug,…
The cybersecurity firm BrandShield has taken down more than 250 websites selling fake versions of popular weight-loss and diabetes drugs in the GLP-1 class, the…
